Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) — Glendale, Arizona

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) is a clinical research site located in Glendale, Arizona, United States 85304.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: DLBCL, Diffuse Large B-Cell Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175)?

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) conducted?

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has 1 clinical trials on record, with 1 currently active. Their work covers DLBCL, Diffuse Large B-Cell Lymphoma.

Is Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) accredited by Crixeo Health?

Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.